Anhui Palo Alto Pharmaceuticals, Inc.

This was an early safety study for a new inhaled steroid medication called PA9159, intended for future use in asthma. The study tested single and repeated doses in 40 healthy Chinese adults to see how their bodies handled the drug and to check for any side effects. The main goal …

This early-stage study tested the safety and how the body processes a new nasal spray called PA9159, intended for treating allergic rhinitis (hay fever). It involved 36 healthy Chinese adults who received either the spray or a placebo for one day or seven days. The main goal was …